Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection : the data collection on adverse events of anti-HIV drugs study. / Kovari, Helen; Sabin, Caroline A; Ledergerber, Bruno; Nielsen, Lene Ryom; Worm, Signe W; Smith, Colette; Phillips, Andrew; Reiss, Peter; Fontas, Eric; Petoumenos, Kathy; De Wit, Stéphane; Morlat, Philippe; Lundgren, Jens D; Weber, Rainer.

In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 56, No. 6, 03.2013, p. 870-9.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kovari, H, Sabin, CA, Ledergerber, B, Nielsen, LR, Worm, SW, Smith, C, Phillips, A, Reiss, P, Fontas, E, Petoumenos, K, De Wit, S, Morlat, P, Lundgren, JD & Weber, R 2013, 'Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 56, no. 6, pp. 870-9. https://doi.org/10.1093/cid/cis919

APA

Kovari, H., Sabin, C. A., Ledergerber, B., Nielsen, L. R., Worm, S. W., Smith, C., Phillips, A., Reiss, P., Fontas, E., Petoumenos, K., De Wit, S., Morlat, P., Lundgren, J. D., & Weber, R. (2013). Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(6), 870-9. https://doi.org/10.1093/cid/cis919

Vancouver

Kovari H, Sabin CA, Ledergerber B, Nielsen LR, Worm SW, Smith C et al. Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 Mar;56(6):870-9. https://doi.org/10.1093/cid/cis919

Author

Kovari, Helen ; Sabin, Caroline A ; Ledergerber, Bruno ; Nielsen, Lene Ryom ; Worm, Signe W ; Smith, Colette ; Phillips, Andrew ; Reiss, Peter ; Fontas, Eric ; Petoumenos, Kathy ; De Wit, Stéphane ; Morlat, Philippe ; Lundgren, Jens D ; Weber, Rainer. / Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection : the data collection on adverse events of anti-HIV drugs study. In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013 ; Vol. 56, No. 6. pp. 870-9.

Bibtex

@article{2a77d8df2c2145dbac86d799136a50b6,
title = "Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study",
abstract = "Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.",
keywords = "Adult, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Data Collection, Drug-Related Side Effects and Adverse Reactions, Female, Follow-Up Studies, HIV Infections, Humans, Incidence, Liver Failure, Male, Middle Aged, Prospective Studies, Survival Analysis",
author = "Helen Kovari and Sabin, {Caroline A} and Bruno Ledergerber and Nielsen, {Lene Ryom} and Worm, {Signe W} and Colette Smith and Andrew Phillips and Peter Reiss and Eric Fontas and Kathy Petoumenos and {De Wit}, St{\'e}phane and Philippe Morlat and Lundgren, {Jens D} and Rainer Weber",
year = "2013",
month = mar,
doi = "10.1093/cid/cis919",
language = "English",
volume = "56",
pages = "870--9",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection

T2 - the data collection on adverse events of anti-HIV drugs study

AU - Kovari, Helen

AU - Sabin, Caroline A

AU - Ledergerber, Bruno

AU - Nielsen, Lene Ryom

AU - Worm, Signe W

AU - Smith, Colette

AU - Phillips, Andrew

AU - Reiss, Peter

AU - Fontas, Eric

AU - Petoumenos, Kathy

AU - De Wit, Stéphane

AU - Morlat, Philippe

AU - Lundgren, Jens D

AU - Weber, Rainer

PY - 2013/3

Y1 - 2013/3

N2 - Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.

AB - Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.

KW - Adult

KW - Anti-Retroviral Agents

KW - Antiretroviral Therapy, Highly Active

KW - Data Collection

KW - Drug-Related Side Effects and Adverse Reactions

KW - Female

KW - Follow-Up Studies

KW - HIV Infections

KW - Humans

KW - Incidence

KW - Liver Failure

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - Survival Analysis

U2 - 10.1093/cid/cis919

DO - 10.1093/cid/cis919

M3 - Journal article

C2 - 23090925

VL - 56

SP - 870

EP - 879

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -

ID: 105603520